Stay informed. See MDA updates on COVID-19

Innovations in Care

We provide programs and services that transform the lives of people affected by neuromuscular disease.

MDA Engage: Gene Therapy and Duchenne Muscular Dystrophy

Recorded: May 20, 2021MDA Engage Logo
On-Demand event

There is no cost to members of the MDA community or healthcare providers to attend the event, however registration is required. Members of the biopharma industry interested in sponsoring or attending should contact the MDA Healthcare Partnerships team at MDAPartners@mdausa.org. For all other questions, please reach out to mdaengage@mdausa.org.

Watch recorded webinar

Gene therapy is being studied as a potential treatment option for DMD (Duchenne Muscular Dystrophy). This webinar will explore what gene therapy is and how it works for individuals living with DMD. The landscape of DMD gene therapy research will also be discussed. The featured presenter of this webinar is neurologist at Texas Children’s Hospital, Farida Abid, MD.

Farida Abid, MD.
Farida Abid, MD.

Live questions will be taken during the webinar. Not available to join live on May 20?  This webinar will be recorded for on-demand viewing.

If you have questions about this webinar or other MDA Engage programs, please reach out to mdaengage@mdausa.org or you may contact our MDA Resource Center at 1-833-ASK-MDA1 (275-6321) or ResourceCenter@mdausa.org.